Nystatin, Neomycin Sulfate, Thiostrepton, Triamcinolone Acetonide

28 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

1430.0%

Death Rate

Active Ingredients

Nystatin, Neomycin Sulfate, Thiostrepton, Triamcinolone Acetonide

Administration Routes

TopicalUnknownAuricular (Otic)Oral

Species Affected

Dog 24

Cat 4

Most Affected Breeds

Domestic Shorthair 3

Retriever - Labrador 3

Crossbred Canine/dog 2

Pinscher - Miniature 2

Bulldog 1

Deutsche Dogge, Great Dane 1

Alaskan Malamute 1

Mixed (Dog) 1

Retriever - Golden 1

Terrier - Yorkshire 1

Most Reported Reactions

Vomiting 5

Diarrhoea 4

Lack of efficacy - NOS 4

Not eating 4

Pain NOS 3

Lethargy (see also Central nervous system depression in 'Neurological') 3

Death 3

Skin disorders NOS 3

Ataxia 3

Skin lesion NOS 2

Decreased appetite 2

Lymphadenopathy 2

Outcome Breakdown

Ongoing

18 (64.3%)

Recovered/Normal

4 (14.3%)

Died

3 (10.7%)

Outcome Unknown

2 (7.1%)

Euthanized

1 (3.6%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.